Metraipolis › archive › dc_650ee7ed4c77

Decoding incretin resistance: a mechanistic framework to reclassify therapeutic variability for GLP-1 receptor agonist therapy — Europe PMC PMID:41236578

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41236578
DOI
10.1007/s00726-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-08T13:25:43.439Z
SHA-256 of the archived text
3103aa40040a24c8f9aed607befbcf06521931b65d5cf5ddc3fd9a9d06b0b3dd
Stable URL of this page
https://metraipolis.com/documento/dc_650ee7ed4c77

How to cite

Decoding incretin resistance: a mechanistic framework to reclassify therapeutic variability for GLP-1 receptor agonist therapy — Europe PMC PMID:41236578 — Europe PMC (en), https://europepmc.org/article/MED/41236578 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_650ee7ed4c77 (Metraipolis archive dc_650ee7ed4c77, sha256 3103aa40040a24c8f9aed607befbcf06521931b65d5cf5ddc3fd9a9d06b0b3dd)
BibTeX
@misc{dc650ee7ed4c77,
  title = {Decoding incretin resistance: a mechanistic framework to reclassify therapeutic variability for GLP-1 receptor agonist therapy — Europe PMC PMID:41236578},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41236578},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_650ee7ed4c77; sha256 3103aa40040a24c8f9aed607befbcf06521931b65d5cf5ddc3fd9a9d06b0b3dd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41236578. Agents can read the archived copy with the MCP tool read_document.